WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DNA past revenue growth

How has DNA's revenue growth performed historically?
Company
-47.36%
Industry
149.51%
Market
17.15%
DNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DNA earnings and revenue history

Current Revenue
$251.5M
Current Earnings
-$892.9M
Current Profit Margin
-355.1%

DNA Return on Equity

Current Company
-65.4%
Current Industry
-63.5%
Current Market
188%
DNA's Return on Equity (-65.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DNA announces earnings.

DNA Return on Assets

Current Company
-42.5%
Current Industry
2.9%
DNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DNA Return on Capital Employed

Current Company
-59.46%
Current Industry
19.5%
DNA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DNA$251.46M-$792.98M-$892.87M+46.77%N/A
MRVI$288.95M$731.76M-$119.03M+18.47%N/A
RNA$9.56M-$207.14M-$212.22M+90.71%N/A
GLPG$260.57M$240.55M$230.11M-5.51%+5.12%
FUSN$2.07M-$85.08M-$94.90M+19.84%N/A
View Top Biotech Stocks

DNA earnings dates

Next earnings date
May 13, 2024

Ginkgo Bioworks Holdings Earnings & Revenue FAQ

What were DNA's earnings last quarter?

On Invalid Date, Ginkgo Bioworks Holdings (NYSE: DNA) reported Q4 2023 earnings per share (EPS) of -$0.11, up 83.33% year over year. Total Ginkgo Bioworks Holdings earnings for the quarter were -$211.69 million. In the same quarter last year, Ginkgo Bioworks Holdings's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.

What was DNA's earnings growth in the past year?

As of Q2 2024, Ginkgo Bioworks Holdings's earnings has grown year over year. Ginkgo Bioworks Holdings's earnings in the past year totalled -$892.87 million.

What is DNA's earnings date?

Ginkgo Bioworks Holdings's earnings date is Invalid Date. Add DNA to your watchlist to be reminded of DNA's next earnings announcement.

What was DNA's revenue last quarter?

On Invalid Date, Ginkgo Bioworks Holdings (NYSE: DNA) reported Q4 2023 revenue of $34.76 million up 64.64% year over year. In the same quarter last year, Ginkgo Bioworks Holdings's revenue was $98.29 million.

What was DNA's revenue growth in the past year?

As of Q2 2024, Ginkgo Bioworks Holdings's revenue has grown -47.36% year over year. This is 196.88 percentage points lower than the US Biotechnology industry revenue growth rate of 149.51%. Ginkgo Bioworks Holdings's revenue in the past year totalled $251.46 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.